Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 15
1966 25
1967 25
1968 26
1969 27
1970 27
1971 33
1972 35
1973 49
1974 75
1975 91
1976 82
1977 94
1978 98
1979 99
1980 117
1981 132
1982 87
1983 130
1984 91
1985 105
1986 165
1987 122
1988 118
1989 129
1990 164
1991 166
1992 146
1993 152
1994 160
1995 161
1996 182
1997 183
1998 198
1999 229
2000 217
2001 184
2002 167
2003 214
2004 194
2005 206
2006 232
2007 258
2008 247
2009 238
2010 250
2011 260
2012 256
2013 269
2014 271
2015 273
2016 248
2017 226
2018 224
2019 212
2020 226
2021 195
2022 212
2023 171
2024 113

Text availability

Article attribute

Article type

Publication date

Search Results

8,693 results

Results by year

Filters applied: . Clear all
Page 1
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. ...Nonetheless, …
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the effic …
Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial.
Duggan C, Wang CY, Xiao L, McTiernan A. Duggan C, et al. Cancer Prev Res (Phila). 2014 Sep;7(9):906-12. doi: 10.1158/1940-6207.CAPR-14-0109. Epub 2014 Jun 12. Cancer Prev Res (Phila). 2014. PMID: 24924486 Free PMC article. Clinical Trial.
Epidemiologic studies suggest a reduced risk of breast cancer among women who use aspirin. A plausible mechanism is through aspirin's effect on estrogens, possibly mediated through interference with estrogen synthesis via reduction in inflammation, which is i …
Epidemiologic studies suggest a reduced risk of breast cancer among women who use aspirin. A plausible mechanism is through aspiri …
ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy.
Rolnik DL, Syngelaki A, O'Gorman N, Wright D, Poon LC, Nicolaides KH. Rolnik DL, et al. Ultrasound Obstet Gynecol. 2023 Jun;61(6):691-697. doi: 10.1002/uog.26222. Ultrasound Obstet Gynecol. 2023. PMID: 37058400 Free article. Clinical Trial.
OBJECTIVES: The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout pregnancy are unknown. ...Generalized additive mixed models with treatment by gestational age interaction terms were used to investigate the eff …
OBJECTIVES: The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout preg …
Aspirin revisited.
Rodvein R, Cooke AR. Rodvein R, et al. Ser Haematol. 1975;8(3):141-50. Ser Haematol. 1975. PMID: 790585 Review.
Short- and long-term impact of aspirin cessation in older adults: a target trial emulation.
Zhou Z, Webb KL, Nelson MR, Woods RL, Ernst ME, Murray AM, Chan AT, Tonkin A, Reid CM, Orchard SG, Kirpach B, Shah RC, Stocks N, Broder JC, Wolfe R. Zhou Z, et al. BMC Med. 2024 Jul 29;22(1):306. doi: 10.1186/s12916-024-03507-8. BMC Med. 2024. PMID: 39075484 Free PMC article. Clinical Trial.
BACKGROUND: The net benefit of aspirin cessation in older adults remains uncertain. This study aimed to use observational data to emulate a randomized trial of aspirin cessation versus continuation in older adults without cardiovascular disease (CVD). ...The two gro …
BACKGROUND: The net benefit of aspirin cessation in older adults remains uncertain. This study aimed to use observational data to emu …
The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
Nuss EE, Hoffman MK, Goudar SS, Kavi A, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bauserman M, Tembo AM, Chomba E, Carlo WA, Figueroa L, Krebs NF, Jessani S, Saleem S, Goldenberg RL, Kurhe K, Das P, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Bucher S, Goco N, Hemingway-Foday J, Moore J, McClure EM, Silver RM, Derman RJ; Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group. Nuss EE, et al. Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. doi: 10.1016/j.ajogmf.2023.101095. Epub 2023 Aug 12. Am J Obstet Gynecol MFM. 2023. PMID: 37574046 Free PMC article. Clinical Trial.
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality was similar in nulliparous women with and without additional risk factors. Professional societies should consider recommending low-dose a …
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality …
Antiplatelet effect of ginkgo diterpene lactone meglumine injection in acute ischemic stroke: A randomized, double-blind, placebo-controlled clinical trial.
Chen C, Lv H, Shan L, Long X, Guo C, Huo Y, Lu L, Zhou Y, Liu M, Wu H, Zhu D, Han Y. Chen C, et al. Phytother Res. 2023 May;37(5):1986-1996. doi: 10.1002/ptr.7720. Epub 2023 Jan 6. Phytother Res. 2023. PMID: 36609866 Clinical Trial.
In this randomized, double-blind, placebo-controlled trial, we randomly assigned 70 inpatients within 48 hr after the onset of AIS to combination therapy with GDLI and aspirin (GDLI at a dose of 25 mg/d for 14 days plus aspirin at a dose of 100 mg/d for 90 days) or …
In this randomized, double-blind, placebo-controlled trial, we randomly assigned 70 inpatients within 48 hr after the onset of AIS to combin …
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Sammons EL, Buck G, Bowman LJ, Stevens WM, Hammami I, Parish S, Armitage J; ASCEND Study Collaborative Group. Sammons EL, et al. Ophthalmology. 2024 Jul;131(7):771-779. doi: 10.1016/j.ophtha.2024.01.018. Epub 2024 Jan 17. Ophthalmology. 2024. PMID: 38237868 Clinical Trial.
PURPOSE: Preclinical studies support a protective role for aspirin in early diabetic retinopathy (DR), but the findings from randomized trials are limited. ...DISCUSSION: These data exclude any clinically meaningful benefits of aspirin for DR, but give reassurance r …
PURPOSE: Preclinical studies support a protective role for aspirin in early diabetic retinopathy (DR), but the findings from randomiz …
Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas.
Barry EL, Fedirko V, Jin Y, Liu K, Mott LA, Peacock JL, Passarelli MN, Baron JA, Jones DP. Barry EL, et al. Cancer Prev Res (Phila). 2022 Aug 1;15(8):521-531. doi: 10.1158/1940-6207.CAPR-21-0555. Cancer Prev Res (Phila). 2022. PMID: 35653338 Free PMC article. Clinical Trial.
We employed an untargeted plasma metabolomics approach using liquid chromatography with high-resolution mass spectroscopy to explore novel metabolites that may contribute to the chemopreventive effects of aspirin. Associations between levels of metabolic features in plasma …
We employed an untargeted plasma metabolomics approach using liquid chromatography with high-resolution mass spectroscopy to explore novel m …
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M, Sanak M, Bochenek G, Stręk P, Ćmiel A, Gielicz A, Plutecka H, Szczeklik A, Niżankowska-Mogilnicka E. Świerczyńska-Krępa M, et al. J Allergy Clin Immunol. 2014 Oct;134(4):883-90. doi: 10.1016/j.jaci.2014.02.041. Epub 2014 Apr 24. J Allergy Clin Immunol. 2014. PMID: 24767875 Clinical Trial.
BACKGROUND: Numerous open trials have demonstrated the beneficial clinical effects of aspirin desensitization (AD) in patients with aspirin-induced asthma (AIA). These beneficial effects might be attributable to aspirin's potent anti-inflammatory prope …
BACKGROUND: Numerous open trials have demonstrated the beneficial clinical effects of aspirin desensitization (AD) in patients with …
8,693 results